Month: <span>October 2019</span>

Home / 2019 / October
Post

From sleeping cell to assassin — how immune cells work

Scientists at the University of Dundee have carried out one of the most comprehensive studies into how immune cells sense and respond to their environment to fight infection and destroy tumours. UNIVERSITY OF DUNDEE Scientists at the University of Dundee have carried out one of the most comprehensive studies into how immune cells sense and...

Post

Gene therapy for Duchenne muscular dystrophy safely preserves muscle function

by Perelman School of Medicine at the University of Pennsylvania A gene therapy being developed at Penn Medicine to treat Duchenne muscular dystrophy (DMD) successfully and safely stopped the severe muscle deterioration associated with the rare, genetic disease in both small and large animal models, according to a first-of-its-kind study from Penn Medicine researchers. The...

Post

Common genetic variant explains why immunotherapy often fails in Crohn’s disease

By Lois Zoppi, BAReviewed by Kate Anderton, B.Sc. (Editor) The reason why a commonly used range of drugs is not effective in some patients living with Crohn’s disease has so far not been identified. However, a collaboration between the University of Exeter, Royal Devon & Exeter NHS Foundation Trust and the Wellcome Sanger Institute has discovered a genetic marker...

Post

New metabolic discovery may inform heart disease, diabetes solutions

Posted Yesterday Science may be inching closer to thwarting obesity, heart disease and Type 2 diabetes, as Cornell biochemists have uncovered a key step in how the human body metabolizes sugar, according to new research published in the Journal of Biological Chemistry. Martha S. Field, assistant professor of nutritional sciences, has further characterized this human metabolic pathway, by identifying two enzymes called sorbitol dehydrogenase (SORD)...

Post

Delivery system can make RNA vaccines more powerful

Posted YesterdayThis news or article is intended for readers with certain scientific or professional knowledge in the field. Vaccines made from RNA hold great potential as a way to treat cancer or prevent a variety of infectious diseases. Many biotech companies are now working on such vaccines, and a few have gone into clinical trials....

Post

Young adults of South Asian descent face higher risk of prediabetes, diabetes: study

by University of Toronto Compared to long-term residents, immigrants to Canada have a 40 percent higher risk of developing prediabetes, which is an early predictor of an individual’s likelihood of developing Type 2 diabetes and associated illnesses, like heart disease. Researchers from the University of Toronto’s Institute of Health Policy, Management and Evaluation in the...

Post

Blocking a hormone’s action in immune cells may reduce heart disease risk

by American Physiological Society Blocking the mineralocorticoid receptor (MR)—a protein that helps maintain normal levels of salt and water in the body—in immune cells may help reduce the risk of heart attack and stroke by improving blood vessel health. The study will be presented today at the American Physiological Society (APS) Aldosterone and ENaC in...

Post

Scientists have identified the presence of cancer-suppressing cells in pancreatic cancer

by Nagoya University A research team led by Nagoya University has revealed that cells containing a protein called Meflin have a role in restraining the progression of pancreatic cancer, a type of cancer that is hard to treat with traditional anti-cancer drugs. The team has also shown that cancer progression can be limited by artificially...